Next-Generation Sequencing in Precision Medicine Market Size, Share, Growth, Report 2025 To 2034

The global next-generation sequencing in precision medicine market size was valued at USD 6.21 billion in 2024 and is expected to hit around USD 32.01 billion by 2034, growing at a compound annual growth rate (CAGR) of 17.82% over the forecast period from 2025 to 2034. The next-generation sequencing in precision medicine market is poised for considerable expansion because of its transformative impacts enabling personalized, precise diagnostics and therapeutics. There is an increasing incidence of genetic disorders as well as cancer and rare diseases which are driving a need for genomic-based tailoring of therapies to individual�s genetic make-up. The increase in adoption of next-generation sequencing in oncology, pharmacogenomics, and rare disease detection paired with advanced bioinformatics, declining sequencing costs, and favorable government policies are accelerating market growth. Strategic partnerships between research institutions and biotech companies, along with FDA endorsement of NGS-guided companion diagnostics propel advancement within this paradigm-shifting precision healthcare landscape.